A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales in 2023. Read more
Tag: gsk
China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
China counted more than 10,000 fresh COVID cases on Friday sparking further restrictions on movement, but also eased some travel requirements in a move welcomed by financial markets. Beijing closed Read more
China eases some travel requirements in move welcomed by markets, even as it counts 10,000 new COVID cases in a day
China counted more than 10,000 fresh COVID cases on Friday sparking further restrictions on movement, but also eased some travel requirements in a move welcomed by financial markets. Beijing closed Read more
GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary Endpoint
By Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients with relapsed or refractory multiple myeloma didn’t meet its primary endpoint of progression-free survival. The Read more
GSK lifts 2022 view after third quarter sales of $8.99 billion beat forecasts
GSK PLC on Wednesday raised its guidance for the full year and posted rising sales for the third quarter that beat expectations. The British pharma major GSK, +0.87% GSK, +0.82% Read more
GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine candidate for adults aged over 60 years met its primary endpoint. The U.K.-based maker of Read more
GSK says U.S. FDA approves Boostrix for immunization during pregnancy
GSK PLC GSK, -0.10% said Monday that the U.S. Food and Drug Administration has approved Boostrix for immunization during the third trimester of pregnancy to help prevent pertussis, or whooping Read more
Spero’s stock jumps 188% after GSK licenses experimental antibiotic
Shares of Spero Therapeutics Inc. SPRO, +204.20% soared 188.4% in trading on Thursday morning after the company signed an exclusive license agreement with GlaxoSmithKline GSK, -0.12% for its experimental antibiotic Read more
GSK defends Zantac ahead of trials that have cratered the stock
GSK on Friday put out a statement saying there’s no link between a withdrawn heartburn medication and cancer, helping to stem a slide in its stock that has wiped out Read more
U.S. stocks end mixed as rally tied to cooler inflation data takes breather
U.S. stocks ended mostly lower on Thursday, despite hitting a three-month high early in the session after another batch of July inflation data suggested that surging price gains may be Read more
- 1
- 2